Skip to main content

Books in Life sciences

Elsevier's Life Sciences collection helps researchers get comprehensive coverage and up-to-date information on the study of living organisms, their processes, and interrelationships, spanning disciplines like biology, genetics, and biochemistry, and addressing emerging trends such as genomics, biotechnology, and sustainability, essential for advancing knowledge and driving innovation in the field.

    • Advanced Cancer Research Protocols

      • 1st Edition
      • Volume 198
      • October 3, 2025
      • English
      • Hardback
        9 7 8 0 4 4 3 4 1 4 4 3 5
      • eBook
        9 7 8 0 4 4 3 4 1 4 4 4 2
      Advanced Cancer Research Protocols, Volume 198 is a comprehensive and cutting-edge resource dedicated to the latest methodologies and protocols in the field of cancer research. Topics in this new release include Introduction to Cancer Biology and Current Research Trends, Cell Culture Techniques for Cancer Research, Practical Approaches to Advanced Molecular Biology Techniques, High-throughput sequencing Technologies for Cancer Genomics, Epigenetic Analysis in Cancer Research, Proteomics and Metabolomics in Cancer Biomarker Discovery, In vivo Cancer Modeling Using Mouse Models, and much more.Other sections highlight advances in Advanced Imaging Techniques for Cancer Research, Cancer Stem Cell Analysis and Targeting, Immunotherapy and Cancer Vaccine Development, Gene Editing Techniques in Cancer Research, Single-Cell Analysis in Cancer Research, Liquid Biopsy and Circulating Tumor Cell Analysis, and Exploring the Tumor Microenvironment in Solid Cancer: From Biology to Therapy.
    • Advances in Clinical Chemistry

      • 1st Edition
      • Volume 129
      • October 3, 2025
      • English
      • Hardback
        9 7 8 0 4 4 3 4 2 9 9 9 6
      • eBook
        9 7 8 0 4 4 3 4 3 0 0 0 8
      Advances in Clinical Chemistry series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.
    • Quantitative Human Physiology

      • 3rd Edition
      • October 1, 2025
      • Joseph J Feher
      • English
      • Paperback
        9 7 8 0 1 2 8 2 0 4 7 6 4
      • eBook
        9 7 8 0 1 2 8 2 0 4 8 2 5
      Quantitative Human Physiology: An Introduction, Third Edition, winner of a 2018 Textbook Excellence Award (Texty), is the first text to meet the needs of the undergraduate bioengineering student who is being exposed to physiology for the first time but requires a more analytical/quantitat... approach. This book explores how component behavior produces system behavior in physiological systems. Through text explanation, figures, and equations, it provides the engineering student with a basic understanding of physiological principles, with an emphasis on quantitative aspects. The third edition has been revised with more and expanded problem sets and improved illustrations.
    • Enzymatic Production of Oligosaccharides

      • 1st Edition
      • September 30, 2025
      • Carlos Vera + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 3 7 3 0 0
      • eBook
        9 7 8 0 4 4 3 2 3 7 3 1 7
      Enzymatic Production of Oligosaccharides: From Basic Research to Industrial Production, a volume in the Foundations and Frontiers of Enzymology series, covers the enzymes used for the extraction, synthesis, or modification of oligosaccharides, the biochemical properties of those enzymes, and potential technological applications. The book is divided into three parts, the first of which shares the fundamentals on the enzymatic synthesis of oligosaccharides. The book then explores the enzymatic production of oligosaccharides, considering a range of different oligosaccharides and production processes. Final sections cover the technological properties of oligosaccharides and potential applications across the chemical, biochemical, biotechnology, and food industries.This is a useful reference for researchers working with oligosaccharides across biochemistry, enzymology, biotechnology, food chemistry and related fields.
    • Kratom

      • 1st Edition
      • September 29, 2025
      • Jack E. Henningfield + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 7 4 1 2 1
      • eBook
        9 7 8 0 4 4 3 2 7 4 1 3 8
      Kratom: History, Science and Therapeutic Potential is the first book to address the unregulated, widespread availability of kratom, with its weak opioid and stimulant effects, coupled with limited awareness of it by healthcare professionals. Kratom has great therapeutic utility and medicinal potential, but more study, caution, and possible regulation is needed. It discusses geographical sourcing, historical uses, current worldwide uses, and potential for treatment of other medical conditions. Most exciting for healthcare professionals will be the implications of this substance's potential for treatment of diseases like depression, ADHD, PTSD, and substance-use disorder, particularly opioid use disorder (OUD).Moreover, kratom and its active alkaloid mitragynine are getting remarkable attention at federal and local governments as more than eight million Americans consume this product annually. Yet, the paucity of information for researchers and clinicians is troublesome.
    • Cancer Theranostics, Second Edition

      • 2nd Edition
      • September 29, 2025
      • Xiaoyuan Chen + 2 more
      • English
      • Hardback
        9 7 8 0 4 4 3 2 2 2 5 3 5
      • eBook
        9 7 8 0 4 4 3 2 2 2 5 4 2
      Cancer Theranostics, Second Edition provide updates on new molecular imaging probes and techniques for early detection of cancer and describes molecular imaging-guided cancer therapy. Discussions also include nanoplatforms, incorporating both cancer imaging and therapeutic components, as well as clinical translation and future perspectives. New to this edition is the inclusion of recent developments and a streamlined structure that leads the reader through the content more intuitively, from problem to solution. More illustrations of different forms of cancer theranostics​ are included, and this edition also contains completely new content on DNA and RNA theranostics. In addition, new case studies are featured.This new edition is published in time to meet the needs of medical researchers in a comprehensive manner, encompassing diagnostics, in vivo imaging and its use for image-guided therapy, and a variety of other miscellaneous subjects. This book is a must-have for all research scientists, medical physicists, and physician scientists in cancer experimental therapeutics and molecular imaging.
    • Ovarian Cancer

      • 1st Edition
      • September 29, 2025
      • Bhupendra G. Prajapati + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 3 3 5 3 6 5
      • eBook
        9 7 8 0 4 4 3 3 3 5 3 7 2
      By providing a comprehensive overview of current research findings, emerging therapies, and clinical practices, Ovarian Cancer: Disease, Diagnosis and Treatment is an invaluable resource. It will not only enhance the understanding of ovarian cancer's complex biology among professionals but also guide them in applying this knowledge to improve patient outcomes The book delivers the key knowledge and information needs faced by the audience center around understanding the latest advances in the underlying pathogenesis and treatment of ovarian cancer. This encompasses a broad spectrum of requirements, from grasping the molecular and genetic factors driving ovarian cancer development to staying updated on the latest therapeutic strategies, including targeted therapies and immunotherapies. In 19 chapters Ovarian Cancer: Disease, Diagnosis and Treatment gives a timely and comprehensive coverage of advances in ovarian cancer therapy, particularly highlighting the development and utilization of Nanotheranostics technologies. This focus not only addresses a crucial and cutting-edge area of cancer treatment but also positions the book as a forward- thinking resource that delves into the potential of Nanotheranostics to revolutionize cancer diagnostics and therapy.Ovarian Cancer: Disease, Diagnosis and Treatment targets a specialized audience within the medical and scientific community, focusing on obstetricians and gynecologists, oncologists, cancer researchers, and importantly, patients with ovarian cancer. This audience selection underscores the project's dual aim of advancing scientific knowledge and directly benefiting patient care in the realm of ovarian cancer, bridging the gap between research, clinical application, and patient advocacy.
    • ​​Environmental Greenness and Cardiovascular Health​

      • 1st Edition
      • September 29, 2025
      • William W. Aitken
      • English
      • Paperback
        9 7 8 0 4 4 3 4 3 9 3 8 4
      • eBook
        9 7 8 0 4 4 3 4 3 9 3 9 1
      Environmental Greenness and Cardiovascular Health provides a comprehensive understanding of how environmental factors, particularly green spaces, impact cardiovascular health. The book bridges environmental science and medical research, offering insights into how greenness contributes to the prevention and management of cardiovascular diseases.Environment... Greenness and Cardiovascular Health begins with an introduction to cardiovascular disease and environmental factors, followed by discussions on defining and measuring greenness, historical perspectives, and the physiological and psychological benefits of green spaces. It also covers urban planning, disparities in access to green spaces, longitudinal studies, future research directions, and policy implications. <i>Environment... Greenness and Cardiovascular Health</i> benefits researchers, medical practitioners, urban planners, and policymakers by providing the latest methodologies, practical examples, and policy recommendations. It serves as an essential resource for understanding the intersection of environment and health, promoting informed strategies for improving cardiovascular health through environmental interventions.
    • Artificial Intelligence in e-Health Framework, Volume 2

      • 1st Edition
      • September 29, 2025
      • Sudip Paul + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 1 4 0 6 1 7
      • eBook
        9 7 8 0 4 4 3 1 4 0 6 0 0
      Artificial Intelligence in e-health Framework, Volume Two: Telemedicine Applications, Drug Delivery, Augmented Reality, and Robotics offers a comprehensive exploration of AI’s role in enhancing medical solutions. Through a focus on machine learning, deep learning, and their practical applications, this book aims to bridge the gap between theoretical advancements and real-world healthcare implementations. In addition to telemedicine advancements, the book explores AI-driven drug discovery, virtual and augmented reality innovations, robotics in medicine, and radiotherapy applications. It serves as an indispensable resource for professionals, researchers, and students eager to deepen their understanding of AI's contributions to modern healthcare.
    • New Opioid Receptor Modulators and Agonists

      • 1st Edition
      • September 25, 2025
      • Alan David Kaye + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 6 5 0 4 4
      • eBook
        9 7 8 0 4 4 3 2 6 5 0 5 1
      New Opioid Receptor Modulators and Agonists: Relevance for Pain and Opioid Use Disorder Management provides crucial insights for developing ideal synthetic opioids. It discusses opioid receptor modulators’ structures and mechanisms, and their potential applications in treating pain, misuse, and addiction. This comprehensive resource delves into current research and therapeutic development avenues regarding opioid receptors' structure and function. Sections cover the rationale for developing allosteric modulators, identifying allosteric sites on opioid receptors, and the modulators' modes of action. Readers will gain a thorough understanding of creating ideal synthetic opioids and potential future research.It also explores pharmacogenomics, precision medicine, and various syndromes and comorbidities linked to opioid use. Lastly, it reviews novel synthetic opioids and the risks of misuse and overdose.